Device review: Pulsante™ sphenopalatine ganglion microstimulator

Nenna Nwazota; Srinivas Pyati; Kyle Fisher; Lance Roy

doi:10.2217/pmt-2018-0082

Device review: Pulsante™ sphenopalatine ganglion microstimulator

Nenna Nwazota, Srinivas Pyati, Kyle Fisher, Lance Roy

Research output: Contribution to journal › Review article › peer-review

Abstract

Cluster headache (CH) is a primary headache disorder. The use of neuromodulation in treatment of CH is well documented. The sphenopalatine ganglion (SPG) has long been a target for management of CH. Intervention at the level of the SPG can interrupt the trigemino-autonomic reflex, which mediates CH pain. The Pulsante system is the only device on the market created for SPG stimulation. The Pulsante device consists of the device body, a lead with six stimulating electrodes placed in the pterygopalatine fossa, and a fixation plate to allow anchoring of the device to the maxilla. Stimulation is administered via a patient-controlled handheld remote control held over the cheek. SPG stimulation is an important treatment option for CH patients.

Original language	English (US)
Pages (from-to)	535-541
Number of pages	7
Journal	Pain management
Volume	9
Issue number	6
DOIs	https://doi.org/10.2217/pmt-2018-0082
State	Published - 2019
Externally published	Yes

Keywords

Pulsante microstimulator
cluster headache
neuromodulation
refractory cluster headache
sphenopalatine ganglion stimulation

ASJC Scopus subject areas

Anesthesiology and Pain Medicine

Access to Document

10.2217/pmt-2018-0082

Cite this

@article{1f985d74abc14265ab1b7b8c6422a632,

title = "Device review: Pulsante{\texttrademark} sphenopalatine ganglion microstimulator",

abstract = "Cluster headache (CH) is a primary headache disorder. The use of neuromodulation in treatment of CH is well documented. The sphenopalatine ganglion (SPG) has long been a target for management of CH. Intervention at the level of the SPG can interrupt the trigemino-autonomic reflex, which mediates CH pain. The Pulsante system is the only device on the market created for SPG stimulation. The Pulsante device consists of the device body, a lead with six stimulating electrodes placed in the pterygopalatine fossa, and a fixation plate to allow anchoring of the device to the maxilla. Stimulation is administered via a patient-controlled handheld remote control held over the cheek. SPG stimulation is an important treatment option for CH patients.",

keywords = "Pulsante microstimulator, cluster headache, neuromodulation, refractory cluster headache, sphenopalatine ganglion stimulation",

author = "Nenna Nwazota and Srinivas Pyati and Kyle Fisher and Lance Roy",

note = "Publisher Copyright: {\textcopyright} 2019 {\textcopyright} 2019 Future Medicine Ltd.",

year = "2019",

doi = "10.2217/pmt-2018-0082",

language = "English (US)",

volume = "9",

pages = "535--541",

journal = "Pain management",

issn = "1758-1869",

publisher = "Future Medicine Ltd.",

number = "6",

}

TY - JOUR

T1 - Device review

T2 - Pulsante™ sphenopalatine ganglion microstimulator

AU - Nwazota, Nenna

AU - Pyati, Srinivas

AU - Fisher, Kyle

AU - Roy, Lance

PY - 2019

Y1 - 2019

N2 - Cluster headache (CH) is a primary headache disorder. The use of neuromodulation in treatment of CH is well documented. The sphenopalatine ganglion (SPG) has long been a target for management of CH. Intervention at the level of the SPG can interrupt the trigemino-autonomic reflex, which mediates CH pain. The Pulsante system is the only device on the market created for SPG stimulation. The Pulsante device consists of the device body, a lead with six stimulating electrodes placed in the pterygopalatine fossa, and a fixation plate to allow anchoring of the device to the maxilla. Stimulation is administered via a patient-controlled handheld remote control held over the cheek. SPG stimulation is an important treatment option for CH patients.

AB - Cluster headache (CH) is a primary headache disorder. The use of neuromodulation in treatment of CH is well documented. The sphenopalatine ganglion (SPG) has long been a target for management of CH. Intervention at the level of the SPG can interrupt the trigemino-autonomic reflex, which mediates CH pain. The Pulsante system is the only device on the market created for SPG stimulation. The Pulsante device consists of the device body, a lead with six stimulating electrodes placed in the pterygopalatine fossa, and a fixation plate to allow anchoring of the device to the maxilla. Stimulation is administered via a patient-controlled handheld remote control held over the cheek. SPG stimulation is an important treatment option for CH patients.

KW - Pulsante microstimulator

KW - cluster headache

KW - neuromodulation

KW - refractory cluster headache

KW - sphenopalatine ganglion stimulation

UR - http://www.scopus.com/inward/record.url?scp=85133892886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85133892886&partnerID=8YFLogxK

U2 - 10.2217/pmt-2018-0082

DO - 10.2217/pmt-2018-0082

M3 - Review article

C2 - 31782695

AN - SCOPUS:85133892886

SN - 1758-1869

VL - 9

SP - 535

EP - 541

JO - Pain management

JF - Pain management

IS - 6

ER -

Device review: Pulsante™ sphenopalatine ganglion microstimulator

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this